Very early researchLooking for participantsNCT07586904
What this trial is testing
Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.
Who this might be right for
Melanoma (Skin Cancer)
Xijing Hospital 10